Co-Founder and Director

Sequel Med Tech taps Arecor to test its twiist pump with ultraconcentrated insulin

Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292

Arecor shares soar on US-rooted $11m financing and key drug alliance

Diabetes Devices Market Reaches $33.4 Bn in 2024 | Strong Growth Ahead by 64.8 Bn 2033

Regional Business Leader

Sequel Med Tech, headquartered in Manchester, New Hampshire, is focused on transformative drug-delivery advancements for diabetes management. The Regional Business Leader will be responsible for launching a new insulin pump and leading a field team to achieve commercial goals while ensuring compliance with industry standards.

Regional Business Leader - Desert Mountain

Head of People & Culture

Director, Human Resources

Director, Commercial Learning and Development

Regional Business Leader TN,AR,LA,MS,FL

Sign up with Google

Sign in with Google